Publications

2014
S Eyal, Rasaby, S, and Ekstein, D. 2014. “Concomitant Therapy In People With Epilepsy: Potential Drug-Drug Interactions And Patient Awareness.”. Epilepsy Behav, 31, Pp. 369-76.
RJ Ryu, Eyal, S, Kaplan, HG , Akbarzadeh, A, Hays, K, Puhl, K, Easterling, TR , Berg, SL , Scorsone, KA , Feldman, EM , Umans, JG , Miodovnik, M, and Hebert, MF . 2014. “Pharmacokinetics Of Doxorubicin In Pregnant Women.”. Cancer Chemother Pharmacol, 73, Pp. 789-97.
2013
H Stiebel-Kalish, Eyal, S, and Steiner, I. 2013. “The Role Of Aquaporin-1 In Idiopathic And Drug-Induced Intracranial Hypertension.”. Med Hypotheses., 81, Pp. 1059-62.
2012
M Rubinchik-Stern and Eyal, S. 2012. “Drug Interactions At The Human Placenta: What Is The Evidence?”. Front Pharmacol, 3, Pp. 126.
E Portnoy, Gurina, M, Magdassi, S. , and Eyal, S. 2012. “Evaluation Of The Near Infrared Compound Indocyanine Green As A Probe Substrate Of P-Glycoprotein.”. Mol Pharm, 9, Pp. 3595-601.
2010
S Eyal, Kim, JD , Anderson, GD , Buchanan, ML , Brateng, DA , Carr, D, Woodrum, DE , Easterling, TR , and Hebert, MF . 2010. “Atenolol Pharmacokinetics And Excretion In Breast Milk During The First 6 Months Postpartum.”. J Clinical Pharmacol, 50, Pp. 1301-9.
AJ Claessens, Risler, LJ , Eyal, S, Shen, DD , Easterling, TR , and Hebert, MF . 2010. “Cyp2D6 Mediates 4-Hydroxylation Of Clonidine In Vitro: Implication For Pregnancy-Induced Changes In Clonidine Clearance.”. Drug Metab Dispos, 38, Pp. 1393-6.
S Eyal, Easterling, TR , Carr, D, Umans, JG , Miodovnik, M, Hankins, JDV , Clark, SM , Risler, L, Wang, J, Kelly, EJ , Shen, DD , and Hebert, MF . 2010. “Pharmacokinetics Of Metformin During Pregnancy.”. Drug Metab Dispos, 38, Pp. 833-40.
S Eyal, Ke, B, Muzi, M, Link, JM , Mankoff, DA , Collier, A, and Unadkat, JD . 2010. “Regional P-Glycoprotein Activity And Inhibition At The Human Blood-Brain Barrier As Imaged By Positron Emission Tomography.”. Clin Pharmacol Ther, 87, Pp. 579-85.
2009
S Eyal, Hsiao, P, and Unadkat, JD . 2009. “Drug Interactions At The Blood-Brain Barrier: Fact Or Fantasy?”. Pharmacol Ther, 123, Pp. 80-104.
A Swed, Eyal, S, Madar, I, Kontante, H, Weiss, L, and Hoffman, A. 2009. “The Role Of P-Glycoprotein In Intestinal Transport Versus The Bbb Transport Of Tetraphenylphosphonium (Tpp).”. Mol Pharm, 6, Pp. 1883-90.
S Eyal, Chung, F, Muzi, M, Link, JM , Mankoff, DA , Kaddoumi, A, O’Sullivan, F, Hebert, MF , and Unadkat, JD . 2009. “Simultaneous Pet Imaging Of P-Glycoprotein Inhibition In Multiple Tissues In The Pregnant Non-Human Primate.”. J Nucl Med, 50, Pp. 798-806.
F Chung, Eyal, S, Muzi, M, Link, JM , Mankoff, DA , Kaddoumi, A, Hsiao, P, O’Sullivan, F, and Unadkat, JD . 2009. “Tissue P-Glycoprotein Activity In The Pregnant Nonhuman Primate Changes With Gestational Age.”. Br J Pharmacol, 159, Pp. 394-404.
2008
JD Unadkat, Chung, F, Sasongko, L, Whittington, D, Eyal, S, Mankoff, DA , Collier, AC , Muzi, M, and Link, J. 2008. “Rapid Solid-Phase Extraction Method To Quantify [11C]-Verapamil, And Its [11C]-Metabolites, In Human And Macaque Plasma.”. Nucl Med Biol, 35, Pp. 911-7.
2007
JA Shimshoni, Dalton, EC , Jenkins, A, Eyal, S, Ewan, K, Williams, RS , Pessah, N, B, Yagen , Harwood, AJ , and Bialer, M. 2007. “The Effects Of Central Nervous System-Active Valproic Acid Constitutional Isomers, Cyclopropyl Analogs, And Amide Derivatives On Neuronal Growth Cone Behavior.”. Mol Pharmacol, 71, Pp. 884-92.
2006
S Eyal, Lamb, JG , Smith-Yockman, M, Yagen, B. , Fibach, E. , Altschuler, Y, White, HS, and Bialer, M. 2006. “The Antiepileptic And Anticancer Agent, Valproic Acid, Induces P-Glycoprotein In Human Tumour Cell Lines And In Rat Liver.”. Br J Pharmacol, 149, Pp. 250-60.
2005
S Eyal, Yagen, B. , Shimshoni, J, and Bialer, M. 2005. “Histone Deacetylases Inhibition And Tumor Cells Cytotoxicity By Cns-Active Vpa Constitutional Isomers And Derivatives.”. Biochem Pharmacol, 69, Pp. 1501-8.
2004
S Eyal, Yagen, B. , Sobol, E, Altschuler, Y, and Bialer, M. 2004. “The Activity Of Antiepileptic Drugs As Histone Deacetylase Inhibitors.”. Epilepsia, 45, Pp. 737-44.
A Hoffman, Stepensky, D, Lavi, E, Eyal, S, Klausner, E, and FRIEDMAN, M. 2004. “Pharmacokinetic And Pharmacodynamic Aspects Of Gastroretentive Dosage Forms.”. Int J Pharm, 277, Pp. 141-153.